Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine drops for benzodiazepine switch-therapy in chronic benzodiazepine users
2008-000880-40Phase 3Terminated
- Sponsor
- Italfarmaco
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of paroxetine in anxiety disorder (2 arms), sponsored by Italfarmaco. Started Mar 2009; status: terminated.
02
Drugs
paroxetine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2008-000880-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000880-40.